Skip to main content
. 2020 Oct 26;35(8):2213–2220. doi: 10.1038/s41433-020-01238-7

Table 1.

Patient demographics of whole cohorts, coverage and centration values.

Stage 1 (n = 56) Stage 2 (n = 77) Stage 3 (n = 38) Stage 4 (n = 90) Total (n = 261)
Age
  Min/max 18/37 16/44 17/38 15/48 15/48
  Mean ± SD 26.53 ± 6.03 27.25 ± 7.12 26.84 ± 5.89 27.13 ± 7.54 27 ± 6.82
Sex
  Female (n, %) 22 (40.7%) 36 (46.1%) 20 (52.6%) 30 (33.3%) 108 (41.2%)
  Male (n, %) 34 (59.2%) 41 (53.8%) 18 (47.3%) 60 (66.6%) 153 (58.7%)
Coverage
  Min/max 75/93 71/93 75/90 72/95 71/95
  Mean ± SD 82.7 ± 4.5 83.82 ± 4.2 82.6 ± 4.9 84.07 ± 6.8 83.6 ± 4.5
Centration
  Min/max 82/96 82/98 75/90 81/97 81/98
  Mean ± SD 91.3 ± 3.9 90.5 ± 3.4 90.9 ± 3.5 90.7 ± 3.8 90.7 ± 3.6